Align phenylacetate-CoA ligase (EC 6.2.1.30) (characterized)
to candidate RR42_RS18265 RR42_RS18265 phenylacetate--CoA ligase
Query= BRENDA::B4E7B5 (432 letters) >FitnessBrowser__Cup4G11:RR42_RS18265 Length = 433 Score = 690 bits (1780), Expect = 0.0 Identities = 339/429 (79%), Positives = 378/429 (88%), Gaps = 3/429 (0%) Query: 3 TPLPLEPIETASRDELTALQLERLKWSLRHAYDHSPVYRRKFDEAGVHPDDLKTLADLSR 62 T LPLEPIETASRD L ALQLERL+WSL HAY +SPVYRRKFD AGVHP+ ++TLADL+R Sbjct: 5 TDLPLEPIETASRDALQALQLERLQWSLNHAYQNSPVYRRKFDAAGVHPNQIRTLADLAR 64 Query: 63 FPFTTKGDLRDSYPFGMFAVPQDRISRIHASSGTTGKPTVVGYTAADIDTWANLVARSIR 122 FPFTTK DLRDSYPFGMFAVPQDR++RIHASSGTTGKPTVVGYT DIDTWA +VARSIR Sbjct: 65 FPFTTKQDLRDSYPFGMFAVPQDRVARIHASSGTTGKPTVVGYTLKDIDTWATVVARSIR 124 Query: 123 AAGARRGDKVHVSYGYGLFTGGLGAHYGAERAGLTVIPFGGGQTEKQVQLIQDFRPDIIM 182 AAGARRGDKVH+SYGYGLFTGGLGAHYG E+AGLT IPFGGGQTE+QVQLIQDF+P++IM Sbjct: 125 AAGARRGDKVHISYGYGLFTGGLGAHYGVEKAGLTAIPFGGGQTERQVQLIQDFKPEVIM 184 Query: 183 VTPSYMLSIADEIERQGLDPVQSSLRIGIFGAEPWTNDMRVAIEQRMGIDAVDIYGLSEV 242 VTPSYML+IADE ERQG+DP SSL++GIFGAEPWT +MR+AIE+RMGI AVDIYGLSEV Sbjct: 185 VTPSYMLAIADEFERQGIDPTASSLKVGIFGAEPWTPEMRLAIEKRMGISAVDIYGLSEV 244 Query: 243 MGPGVASECVETKDGPTIWEDHFYPEIIDPETGEVLPDGELGELVFTSLTKEALPIIRYR 302 MGPGVASEC +TKDGPTIWEDHFYPE+IDP TGEVLPDGE GELVFTSL+KEALPI+RYR Sbjct: 245 MGPGVASECAQTKDGPTIWEDHFYPEVIDPLTGEVLPDGEFGELVFTSLSKEALPIVRYR 304 Query: 303 TRDLTRLLPGTAR-TMRRMEKITGRSDDMMIVRGVNVFPTQIEEQLLKQRALAPHYQIVL 361 TRDLTRLLPG+AR RRMEK+TGR+DDMMI+RGVNVFP+QIEE +LK LAPHYQ VL Sbjct: 305 TRDLTRLLPGSARGAFRRMEKVTGRTDDMMIIRGVNVFPSQIEELILKHAELAPHYQCVL 364 Query: 362 TKEGPLDVLTLNVEPCPETAPDTAAIQVAKQALAYDIKSLIGVTAVINVLPVNGIERSVG 421 TK+G LDVLT+ VE C D AA A L YDIK+ IGVT I +LP G+ERSVG Sbjct: 365 TKDGHLDVLTVRVE-CAH-GVDPAATHQASAQLTYDIKAFIGVTVGIEILPSGGVERSVG 422 Query: 422 KARRVVDKR 430 KARR+VD+R Sbjct: 423 KARRIVDQR 431 Lambda K H 0.319 0.137 0.404 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 721 Number of extensions: 18 Number of successful extensions: 3 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 432 Length of database: 433 Length adjustment: 32 Effective length of query: 400 Effective length of database: 401 Effective search space: 160400 Effective search space used: 160400 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate RR42_RS18265 RR42_RS18265 (phenylacetate--CoA ligase)
to HMM TIGR02155 (paaF: phenylacetate-CoA ligase (EC 6.2.1.30))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.carbon/TIGR02155.hmm # target sequence database: /tmp/gapView.20623.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR02155 [M=422] Accession: TIGR02155 Description: PA_CoA_ligase: phenylacetate-CoA ligase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 4.1e-210 683.6 0.0 4.7e-210 683.4 0.0 1.0 1 lcl|FitnessBrowser__Cup4G11:RR42_RS18265 RR42_RS18265 phenylacetate--CoA Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__Cup4G11:RR42_RS18265 RR42_RS18265 phenylacetate--CoA ligase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 683.4 0.0 4.7e-210 4.7e-210 1 422 [] 13 431 .. 13 431 .. 0.98 Alignments for each domain: == domain 1 score: 683.4 bits; conditional E-value: 4.7e-210 TIGR02155 1 eklsldelralqlerlkvsvkrayenvpayrkafdaagvkpddlkelsdlakfpltaksdlrdnypfdl 69 e++s+d l+alqlerl++s+++ay+n p+yr++fdaagv+p+ +++l+dla+fp+t+k+dlrd ypf++ lcl|FitnessBrowser__Cup4G11:RR42_RS18265 13 ETASRDALQALQLERLQWSLNHAYQNSPVYRRKFDAAGVHPNQIRTLADLARFPFTTKQDLRDSYPFGM 81 899****************************************************************** PP TIGR02155 70 lavprekvvrvhassGttGkptvvaytqkdldtwsevvarslraaGGrkgdllhnayGyGlftGGlGvh 138 +avp+++v+r+hassGttGkptvv+yt kd+dtw++vvars+raaG r+gd++h++yGyGlftGGlG+h lcl|FitnessBrowser__Cup4G11:RR42_RS18265 82 FAVPQDRVARIHASSGTTGKPTVVGYTLKDIDTWATVVARSIRAAGARRGDKVHISYGYGLFTGGLGAH 150 ********************************************************************* PP TIGR02155 139 yGaeklGatvvpisGGqtekqvqliqdfkpdiiavtpsyilalleelkrlgidpedislkvailGaepw 207 yG ek G t +p+ GGqte+qvqliqdfkp++i+vtpsy+la+++e++r+gidp+ slkv+i+Gaepw lcl|FitnessBrowser__Cup4G11:RR42_RS18265 151 YGVEKAGLTAIPFGGGQTERQVQLIQDFKPEVIMVTPSYMLAIADEFERQGIDPTASSLKVGIFGAEPW 219 ********************************************************************* PP TIGR02155 208 teamrkelearlgikaldiyGlseviGpGvanecvetkdGlviwedhfypeiidpetgevlpdGeeGel 276 t +mr ++e+r+gi+a+diyGlsev+GpGva ec +tkdG++iwedhfype+idp tgevlpdGe Gel lcl|FitnessBrowser__Cup4G11:RR42_RS18265 220 TPEMRLAIEKRMGISAVDIYGLSEVMGPGVASECAQTKDGPTIWEDHFYPEVIDPLTGEVLPDGEFGEL 288 ********************************************************************* PP TIGR02155 277 vfttltkealpviryrtrdltrllpgtart.mrrmdkikGrsddllilrGvnvfptqleevllkldkls 344 vft+l+kealp++ryrtrdltrllpg+ar rrm+k++Gr+dd++i+rGvnvfp+q+ee++lk +l+ lcl|FitnessBrowser__Cup4G11:RR42_RS18265 289 VFTSLSKEALPIVRYRTRDLTRLLPGSARGaFRRMEKVTGRTDDMMIIRGVNVFPSQIEELILKHAELA 357 *****************************879************************************* PP TIGR02155 345 phyqleltreGaldeltlkvelkdesaalrlleqksllakkiekkikaevgvsvdvelvepgslerseG 413 phyq lt++G+ld lt++ve + + ++ + + ++ +ika++gv+v +e+ +g +ers G lcl|FitnessBrowser__Cup4G11:RR42_RS18265 358 PHYQCVLTKDGHLDVLTVRVECAHGVDPAATH----QASAQLTYDIKAFIGVTVGIEILPSGGVERSVG 422 *********************99666555544....4468999************************** PP TIGR02155 414 kakrvvdkr 422 ka+r+vd+r lcl|FitnessBrowser__Cup4G11:RR42_RS18265 423 KARRIVDQR 431 *******98 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (422 nodes) Target sequences: 1 (433 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 10.53 // [ok]
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory